Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Lindevall Kai Eugen Harald
   2. Issuer Name and Ticker or Trading Symbol
ENCORIUM GROUP INC [ENCO] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Pres. European and Asian Oper.
(Last)
(First)
(Middle)
KEILARANTA 16		 3. Date of Earliest Transaction (Month/Day/Year)
03/27/2007
(Street)

ESPOO, H9 02150		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.001 per share 03/27/2007   J(1)   281,630 A $ 2.83 (2) 1,325,746 D  
Common Stock, $.001 per share 03/27/2007   J(3)   26,370 A $ 2.83 (4) 161,516 I By Spouse (5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Lindevall Kai Eugen Harald
KEILARANTA 16
ESPOO, H9 02150		   X     Pres. European and Asian Oper.  

Signatures

 /s/ Kai Lindevall   03/29/2007
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On March 27, 2007, the reporting person became entitled to receive an additional 281,630 shares of Encorium Group, Inc.'s ("Encorium") common stock pursuant to an "earn-out" provision contained in the Amended and Restated Combination Agreement dated July 6, 2006 (the "Agreement"), pursuant to which Encorium acquired all of the issued and outstanding stock of Remedium Oy ("Remedium") on November 1, 2006. The Agreement provided that the former stockholders of Remedium would receive a variable number of additional shares of Encorium common stock, for no additional consideration, if Remedium's net revenues for the year ending December 31, 2006 reached certain threshold levels contained in the Agreement. Remedium's net revenues for the year ending December 31, 2006 exceeded EUR 9,500,000, but was less that EUR 10,700,000, as a result of which the former stockholders of Remedium, including the reporting person, acquired additional shares of Encorium common stock pursuant to the Agreement.
(2) The number of shares issubable pursuant to the earn-out right was determined pursuant to a formula set forth in the Agreement which provided that, for the purpose of determining the number of shares issuable, Encorium's common stock would be valued at $2.83 per share, representing the price per share at which the former Remedium stockholders received Encorium shares upon the closing of the Agreement.
(3) On March 27, 2007, the reporting person's wife became entitled to receive an additional 26,370 shares of Encorium's common stock pursuant to the earn-out right contained in the Agreement. See footnote 1.
(4) See footnote 2.
(5) The reporting person disclaims beneficial ownership of his wife's shares.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.